Clinical study of TACE combined PEI in treatment of primary hepatic carcinoma
- VernacularTitle:经动脉灌注化疗栓塞联合经皮无水乙醇注射治疗原发性肝癌临床研究
- Author:
Fanglai ZHU
;
Ansheng LING
- Publication Type:Journal Article
- Keywords:
Primary hepatic carcinoma;
Transcatheter hepatic arterial chemoembolization;
Percutaneous ethanol injection
- From:
Journal of Interventional Radiology
1994;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the transcatheter hepatic arterial chemoembolization(TACE) combined percutaneous ethanol injection(PEI)in treating primary hepatic carcinoma and the simple TACE treatment. Methods 64 primary hepatic carcinoma patients were divided into union treatment group(n = 32)and TACE group(n = 32),with TACE combined PEI treatment and simple TACE treatment,respectively. The tumor size,AFP change,one year,two years,three years survival time and median survival time were observed and recorded during the course of treatment. Results The tumor shrinkage rates and the AFP transferring into negative rates of the union and simple TACE groups were 84.4%,62.7% and 77.4%,50% respectively after the treatment with significant difference between the two groups. The 1 years,2 years,3 years and median survival rates of the union and simple TACE groups were 96.9%,71.9%,37.5%,34.5 mo and 81.3%,31.3%,12.5%,19.5 mo,respectively,showing conspicuously significance of both groups. Conclusion TACE combined PEI for primary hepatic carcinoma is a better treatment of choice.
